Action of RORs and their ligands in (patho)physiology

Trends in Endocrinology and Metabolism

Volumn 23, Issue 12, 2012, Pages 619-627

  Solt, Laura A ^a   Burris, Thomas P ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Lipid; Nuclear receptor; Oxysterol; Steroid receptor

Indexed keywords

20ALPHA HYDROXYCHOLESTEROL; 24,25 EPOXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; AGENTS AFFECTING LIPID METABOLISM; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CHOLESTEROL; CHOLESTEROL DERIVATIVE; DIGOXIN; GLUCOSE; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 26; INTERLEUKIN 9; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR BETA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SR 1001; SR 1078; SR 2211; SR 3335; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CIRCADIAN RHYTHM; CYTOKINE RELEASE; DRUG SCREENING; DRUG STRUCTURE; HUMAN; IMMUNOPATHOLOGY; LIGAND BINDING; LIPID METABOLISM; LIPOPROTEIN DEFICIENCY; LYMPHOCYTE DIFFERENTIATION; METABOLIC DISORDER; METABOLISM; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PSORIASIS; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; CIRCADIAN RHYTHM; HUMANS; LIGANDS; METABOLIC DISEASES; MICE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84869489534     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.05.012     Document Type: Review

References (67)

1. Mangelsdorf D.J., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
2. Hummasti S., Tontonoz P. Adopting new orphans into the family of metabolic regulators. Mol. Endocrinol. 2008, 22:1743-1753.
3. Mohan R., Heyman R.A. Orphan nuclear receptor modulators. Curr. Top. Med. Chem. 2003, 3:1637-1647.
4. Giguere V., et al. Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev. 1994, 8:538-553.
5. Carlberg C., et al. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol. Endocrinol. 1994, 8:757-770.
6. Hirose T., et al. ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem. Biophys. Res. Commun. 1994, 205:1976-1983.
7. Jetten A.M. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal. 2009, 7:e003.
8. Wang Y., et al. Modulation of RORα and RORγ activity by 7-oxygenated sterol ligands. J. Biol. Chem. 2009, 285:5013-5025.
9. Duez H., Staels B. Rev-erb-alpha: an integrator of circadian rhythms and metabolism. J. Appl. Physiol. 2009, 107:1972-1980.
10. Solt L.A., et al. The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis. Future Med. Chem. 2011, 3:623-638.
11. Yin L., et al. Nuclear receptor Rev-erbalpha: a heme receptor that coordinates circadian rhythm and metabolism. Nucl. Recept. Signal. 2010, 8:e001.
12. Burris T.P. Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock. Mol. Endocrinol. 2008, 22:1509-1520.
13. Raghuram S., et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat. Struct. Mol. Biol. 2007, 14:1207-1213.
14. Yin L., et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 2007, 318:1786-17189.
15. Hamilton B.A., et al. Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature 1996, 379:736-739.
16. Steinmayr M., et al. Staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3960-3965.
17. Andre E., et al. Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice. EMBO J. 1998, 17:3867-3877.
18. Andre E., et al. A novel isoform of the orphan nuclear receptor RORbeta is specifically expressed in pineal gland and retina. Gene 1998, 216:277-283.
19. Huang W., et al. Circadian rhythms, sleep, and metabolism. J. Clin. Invest. 2011, 121:2133-2141.
20. Akashi M., Takumi T. The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat. Struct. Mol. Biol. 2005, 12:441-448.
21. Guillaumond F., et al. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J. Biol. Rhythms 2005, 20:391-403.
22. Forman B.M., et al. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol. Endocrinol. 1994, 8:1253-1261.
23. Retnakaran R., et al. Identification of RVR, a novel orphan nuclear receptor that acts as a negative transcriptional regulator. Mol. Endocrinol. 1994, 8:1234-1244.
24. Takeda Y., et al. Retinoic acid-related orphan receptor gamma directly regulates neuronal PAS domain protein 2 transcription in vivo. Nucleic Acids Res. 2011, 39:4769-4782.
25. Knutsson A., et al. Shiftwork and myocardial infarction: a case-control study. Occup. Environ. Med. 1999, 56:46-50.
26. Raspe E., et al. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J. Biol. Chem. 2001, 276:2865-2871.
27. Mamontova A., et al. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation 1998, 98:2738-2743.
28. Vu-Dac N., et al. Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha. J. Biol. Chem. 1997, 272:22401-22404.
29. Lau P., et al. The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity. J. Biol. Chem. 2008, 283:18411-18421.
30. Kang H.S., et al. Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol. Genomics 2007, 31:281-294.
31. Liu C., et al. Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism. Nature 2007, 447:477-481.
32. Wada T., et al. Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol. Pharmacol. 2008, 73:891-899.
33. Chopra A.R., et al. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 2008, 322:1395-1399.
34. Wang Y., et al. Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha. J. Biol. Chem. 2010, 285:15668-15673.
35. Meissburger B., et al. Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma. EMBO Mol. Med. 2011, 3:637-651.
36. Littman D.R., Rudensky A.Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010, 140:845-858.
37. Graeber K.E., Olsen N.J. Th17 cell cytokine secretion profile in host defense and autoimmunity. Inflamm. Res. 2012, 61:87-96.
38. Peck A., Mellins E.D. Precarious balance: Th17 cells in host defense. Infect. Immun. 2010, 78:32-38.
39. Korn T., Petermann F. Development and function of interleukin 17-producing gammadelta T cells. Ann. N. Y. Acad. Sci. 2012, 1247:34-45.
40. + T helper cells. Cell 2006, 126:1121-1233.
41. Yang X.O., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29-39.
42. H17/Treg balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
43. Wang Y., et al. A second class of nuclear receptors for oxysterols: regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Biochim. Biophys. Acta 2010, 1801:917-923.
44. Jin L., et al. Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma. Mol. Endocrinol. 2010, 24:923-929.
45. Kallen J.A., et al. X-ray structure of the hRORalpha LBD at 1.63Å: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 2002, 10:1697-1707.
46. Kallen J., et al. Crystal structure of the human RORalpha ligand binding domain in complex with cholesterol sulfate at 2.2Å. J. Biol. Chem. 2004, 279:14033-14038.
47. Volkman J.K. Sterols in microorganisms. Appl. Microbiol. Biotechnol. 2003, 60:495-506.
48. Moraitis A.N., et al. Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Mol. Cell. Biol. 2002, 22:6831-6841.
49. Houck K.A., et al. T0901317 is a dual LXR/FXR agonist. Mol. Genet. Metab. 2004, 83:184-187.
50. Mitro N., et al. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett. 2007, 581:1721-1726.
51. Wang Y., et al. Identification of SR 1078, a synthetic agonist for the orphan nuclear receptors RORalpha and RORgamma. ACS Chem. Biol. 2010, 5:1029-1034.
52. Zhu Y., et al. RORA, a large common fragile site gene, is involved in cellular stress response. Oncogene 2006, 25:2901-2908.
53. Wang Y., et al. Regulation of p53 stability and apoptosis by a ROR agonist. PLoS ONE 2012, 7:e34921.
54. Kumar N., et al. Identification of SR 3335 (ML-176): a synthetic RORalpha selective inverse agonist. ACS Chem. Biol. 2011, 6:218-222.
55. Solt L.A., et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 2011, 472:491-494.
56. Huh J.R., et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 2011, 472:486-490.
57. Fujita-Sato S., et al. Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production. J. Biol. Chem. 2011, 286:31409-31417.
58. Xu T., et al. Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein. J. Biol. Chem. 2011, 286:22707-22710.
59. Pathak A.K., et al. Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol. Cancer Res. 2007, 5:943-955.
60. Wang X., et al. Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J. Biomed. Biotechnol. 2011, 2011:419343.
61. Kumar N., et al. Identification of SR 2211: a potent synthetic RORgamma-selective modulator. ACS Chem. Biol. 2012.
62. Wang N.S., et al. Divergent transcriptional programming of class-specific B cell memory by T-bet and RORalpha. Nat. Immunol. 2012, 13:604-611.
63. + innate lymphocytes. Immunity 2010, 33:736-751.
64. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
65. Oukka M. Th17 cells in immunity and autoimmunity. Ann. Rheum. Dis. 2008, 67(Suppl. 3):iii26-iii29.
66. Kumar N., et al. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-(alpha)/(gamma) inverse agonist. Mol. Pharmacol. 2010, 77:228-236.
67. Schultz J.R., et al. Role of LXRs in control of lipogenesis. Genes Dev. 2000, 14:2831-2838.